Cargando…

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy

Immunogenic cell death (ICD) activates both innate and adaptive arms of the immune system during apoptotic cancer cell death. With respect to cancer immunotherapy, the process of ICD elicits enhanced adjuvanticity and antigenicity from dying cancer cells and consequently, promotes the development of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruickshank, Brianne, Giacomantonio, Michael, Marcato, Paola, McFarland, Sherri, Pol, Jonathan, Gujar, Shashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891575/ https://www.ncbi.nlm.nih.gov/pubmed/29666625 http://dx.doi.org/10.3389/fimmu.2018.00654

Ejemplares similares

Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy
por: Konda, Prathyusha, et al.
Publicado: (2020)

ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
por: Vidovic, Dejan, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
por: Holay, Namit, et al.
Publicado: (2017)

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
por: Gujar, Shashi, et al.
Publicado: (2018)

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
por: Gujar, Shashi, et al.
Publicado: (2020)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Xinwen, et al.
Publicado: (2021)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)

The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity
por: Walsh, Hayley R., et al.
Publicado: (2019)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immunogenic Cell Death Induction by Ionizing Radiation
por: Zhu, Mengqin, et al.
Publicado: (2021)

Immunogenic Cell Death-Based Cancer Vaccines
por: Jin, Ming-Zhu, et al.
Publicado: (2021)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Influences of Vitamin A on Vaccine Immunogenicity and Efficacy
por: Penkert, Rhiannon R., et al.
Publicado: (2019)

After virus exposure, early bystander naïve CD8 T cell activation relies on NAD(+) salvage metabolism
por: Holay, Namit, et al.
Publicado: (2023)

Therapeutic Implications of Immunogenic Cell Death in Human Cancer
por: Palombo, Fabio, et al.
Publicado: (2014)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
por: Garg, Abhishek D., et al.
Publicado: (2015)

Immunogenic cell death as driver of autoimmunity in granulomatosis with polyangiitis
por: Brieske, Christoph, et al.
Publicado: (2022)

Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model()()
por: Mathenge, Edward Gitau, et al.
Publicado: (2014)

Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis
por: Dahn, Margaret L., et al.
Publicado: (2022)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Research progress in inducing immunogenic cell death of tumor cells
por: Xie, Deqian, et al.
Publicado: (2022)

Condemned or Not to Die? Gene Polymorphisms Associated With Cell Death in Pemphigus Foliaceus
por: Bumiller-Bini, Valéria, et al.
Publicado: (2019)

Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation
por: Fabian, Kellsye P., et al.
Publicado: (2022)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
por: Rausch, Johanna, et al.
Publicado: (2023)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
por: Hannani, Dalil
Publicado: (2015)

Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
por: Zhu, Songxin, et al.
Publicado: (2022)

Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
por: Bhat, Jaydeep, et al.
Publicado: (2018)

An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer
por: Sultan, Mohammad, et al.
Publicado: (2021)

Experimental immunotherapies for multiple sclerosis
por: Martin, Roland, et al.
Publicado: (1996)

Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
por: Garg, Abhishek D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n6nuo2u1p808b4mjtsuoh9qhrk